Evaluation of information theoretic network meta-analysis to rank first-line anticancer regimens for hormone receptor–positive, ERBB2-negative metastatic breast cancer.

Evaluation of Information Theoretic Network Meta-analysis to Rank First-Line Anticancer Regimens for Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer – JAMA Network Open

Invited Commentary: Navigating Systemic Therapeutic Options for First-Line Metastatic Hormone Receptor–Positive, ERBB2-Negative Breast Cancer Treatment – JAMA Network Open